COVID-19 Bivalent Vaccine Boosters Have Been Authorized for School Age Children | FDA

The FDA authorized bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines for use as a single booster dose at least two months after completing primary or booster vaccination.The Moderna COVID-19 Vaccine, Bivalent is authorized for use as single booster dose in individuals 6 years of age and older.

The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorized for use as a single booster dose in individuals 5 years of age and older.

Source: COVID-19 Bivalent Vaccine Boosters | FDA